Is Boehringer Ingelheim Espa�a, S.A. FDA approved?

Boehringer Ingelheim Espa�a, S.A. holds 1 FDA-registered establishment in Spain. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Boehringer Ingelheim Espa�a, S.A.'s drugs manufactured?

The FDA register lists Sant Cugat del Vall�s. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, relabelling, repackaging.

Boehringer Ingelheim Espa�a, S.A.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 0
Live patents: 0
Countries: 1
Base: Spain

Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1Relabelling1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Boehringer Ingelheim Espa�a, S.A.	Prat de la Riba, 50, Sant Cugat del Vall�s, Barcelona 08174, Spain (ESP)	Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging	3008772184465561546

Compare

Comparable companies in Spain

QUIMICA SINTETICA SA1 site · 58 NDC
Derivados Quimicos SAU1 site · 38 NDC
Interquim, S.A.1 site · 26 NDC
Farmhispania S.A.1 site · 17 NDC
Rolabo Outsourcing S.L.1 site · 9 NDC
AGC Pharma Chemicals Europe, S.L.U .1 site · 7 NDC
BERIOSKA SL1 site · 7 NDC
Ercros SA1 site · 7 NDC
Towa Pharmaceutical Europe, S.L.1 site · 6 NDC
Quality Chemicals S.L.1 site · 3 NDC

Enquiry

Common questions

Is Boehringer Ingelheim Espa�a, S.A. FDA approved?: Boehringer Ingelheim Espa�a, S.A. holds 1 FDA-registered establishment in Spain. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Boehringer Ingelheim Espa�a, S.A.'s drugs manufactured?: The FDA register lists Sant Cugat del Vall�s. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, relabelling, repackaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.